CIK: 1615096 - Address: C/o Adverum Biotechnologies, Inc., 1035 O'Brien Drive, Suite A, Menlo Park, CA 94025
7 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret117-2-4-21-53-71-86-39
S%wins86717110010010088

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/17/15 20:33
6/15/15
AAVLAvalanche Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagSchwartz Steven DanielCADS-67339.8625-17-4368D-66-60-42-56-58-58-5-3-2-36-50
6/2/15 20:24
6/1/15
AAVLAvalanche Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagSchwartz Steven DanielCADS-62536.2312-17-4385D-71-67-5-500-57-72-74
5/22/15 19:21
5/22/15
AAVLAvalanche Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagSchwartz Steven DanielCADS-64838.3811-17-4402D15-3-517156-3-2-56-72-76
5/11/15 17:00
5/8/15
AAVLAvalanche Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagSchwartz Steven DanielCADS-57033.0511-17-4419D-3-2-16-18-710-317-64-79-95
4/23/15 19:52
4/23/15
AAVLAvalanche Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagSchwartz Steven DanielCADS-65238.6214-17-4436D29-610-1-3-2-91-56-78-83
4/13/15 16:47
4/9/15
AAVLAvalanche Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagSchwartz Steven DanielCADS-68539.7316-17-4451D30-3112-90523-11-56-76-84
1/15/15 16:58
1/13/15
AAVLAvalanche Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagSchwartz Steven DanielCADS-5,04755.4618-91-16468D904317-3-3-6-15-27-17-62-80

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact